Related Experiment Video
Updated: Aug 19, 2026

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
[Systolic heart failure in the elderly]
1Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar. kilter@med-in.uni-sb.de
Insights
Aging hearts experience increased vascular stiffness, raising blood pressure and heart workload. Standard heart failure medications are effective in older adults but require careful dosing and monitoring due to age-related physiological changes.
Area of Science:
- Cardiovascular Physiology
- Gerontology
- Pharmacology
Context:
- Aging alters cardiac and vascular structures, increasing heart failure risk.
- Increased vascular stiffness elevates systolic pressure and pulse wave velocity, augmenting cardiac afterload.
- Age-associated sympathetic nervous system changes resemble those in congestive heart failure.
Purpose:
- To review the impact of aging on cardiac and vascular function.
- To discuss the implications for heart failure development and treatment in the elderly.
- To outline therapeutic strategies for systolic heart failure in older populations.
Summary:
- Aging leads to vascular stiffening, increased systolic pressure, and cardiac hypertrophy.
- Molecular changes in the aging sympathetic nervous system mirror those in heart failure.
- Standard heart failure therapies, including ACE inhibitors, beta-blockers, and aldosterone antagonists, are indicated for elderly patients.
Impact:
- Highlights the need for individualized treatment initiation, dosage adjustment, and close monitoring in elderly patients.
- Emphasizes that effective heart failure management in the elderly relies on established pharmacological interventions.
- Underscores the importance of considering comorbidities and altered pharmacokinetics/pharmacodynamics in geriatric cardiovascular care.
Abstract:
Aging is associated with changes in cardiac and vascular structure, promoting the development of heart failure. An increase in vascular stiffness leads to an increase of systolic arterial pressure and pulse wave velocity. This augments the afterload of the heart, which contributes to cardiac hypertrophy and neuroendocrine activation in the elderly. On the molecular level the age-associated changes in the sympathetic nervous system are similar to alterations that can be found in congestive heart failure. Therapy of systolic heart failure does not differ between the elderly and younger patients. All drugs which have shown to improve the prognosis of younger patients are indicated in the elderly as well. This holds true for ACE-inhibitors or angiotensin receptor antagonists, betablockers and aldosterone antagonists. However, comorbidities as well as changes in the pharmacokinetics and pharmacodynamics might require a cautious initiation of the therapy, an individual adjustment of the dosage and a thoroughly monitoring of the elderly patients.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
